Vise Technologies Inc. purchased a new position in Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,194 shares of the real estate investment trust’s stock, valued at approximately $550,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in VTR. Dynamic Wealth Strategies LLC purchased a new stake in Ventas during the 1st quarter valued at approximately $25,000. Wiser Advisor Group LLC purchased a new position in shares of Ventas in the third quarter worth $27,000. Meeder Asset Management Inc. purchased a new position in shares of Ventas in the second quarter worth $30,000. IFC & Insurance Marketing Inc. bought a new position in shares of Ventas during the fourth quarter worth $30,000. Finally, Elyxium Wealth LLC bought a new position in shares of Ventas during the fourth quarter worth $33,000. 94.18% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on the stock. Jefferies Financial Group lifted their price target on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. BMO Capital Markets raised their price objective on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. Wells Fargo & Company lifted their target price on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Barclays started coverage on Ventas in a research report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 target price on the stock. Finally, Citigroup increased their price target on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average price target of $98.00.
Insider Buying and Selling
In related news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.53% of the company’s stock.
Ventas Price Performance
VTR stock opened at $93.47 on Tuesday. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The company has a fifty day simple moving average of $91.56 and a two-hundred day simple moving average of $87.26. The firm has a market capitalization of $47.94 billion, a P/E ratio of 173.09, a price-to-earnings-growth ratio of 2.15 and a beta of 0.69.
Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business had revenue of $1.73 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the company posted $0.87 EPS. The business’s revenue was up 21.7% on a year-over-year basis. Analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
